Loading...
*  DNA vaccination
Second generation vaccines were developed to reduce the risks from live vaccines. These are subunit vaccines, consisting of ... Oliveira, PH; Mairhofer, J (2013). "Marker-free plasmids for biotechnological applications - implications and perspectives". ... First generation vaccines are whole-organism vaccines - either live and weakened, or killed forms. Live, attenuated vaccines, ... A veterinary DNA vaccine to protect horses from West Nile virus has been approved. DNA vaccines elicit the best immune response ...
*  Marker vaccine
A marker vaccine allows for immunological differentiation (or segregation) of infected from vaccinated animals, and is also ... thus creating a negative marker of vaccination. In contrast, vaccination with traditional vaccines containing the complete ... "Vaccine Safety and Efficacy Evaluation of a Recombinant Bovine Respiratory Syncytial Virus (BRSV) with Deletion of the SH Gene ... can be used to continuously monitor the efficacy and safety of the vaccine. van Oirschot, J. T.; Rziha, H. J.; Moonen, P. J.; ...
*  Bovine herpesvirus 1
Marker vaccines are also available and recommended. Marker vaccines, also known as DIVA (differentiation of infected from ... herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine". ... A marker vaccine uses either deletion mutants or a virion subunit, such as glycoprotein E. Studies show that vaccinating after ... Using a killed gE deleted marker vaccine after infection will reduce viral excretion following reactivation, using a ...
*  India National PolioPlus
are being supported with IEC materials - vaccine carriers, marker pens, cap/aprons, cold boxes, etc. - and free general health ... 1961: Dr Albert Sabin develops an" oral polio vaccine (OPV) using attenuated poliovirus. The OPV rapidly becomes the vaccine of ... Jonas Salk develops the first vaccine against polio - an injectable, inactivated (killed) polio vaccine. ... That the vaccine had parts of animals in it, so it would be haram [forbidden] under Islam, and that it was a plot by the US and ...
*  Classical swine fever
... as well as using marker and emergency vaccines to inhibit the spread of infection. Possible sources for maintaining and ... This may possibly be followed by emergency vaccination (ATCvet codes: QI09AA06 (WHO) for the inactivated viral vaccine, ... QI09AD04 (WHO) for the live vaccine). Vaccination is only used where the virus is widespread in the domestic pig population and ...
*  Dinitrophenyl
"Activation markers on T cells infiltrating melanoma metastases after therapy with dinitrophenyl-conjugated vaccine". Cancer ... It is a hapten used in vaccine preparation. Dinitrophenyl does not elicit any immune response on its own and it does not bind ... rearrangement in lymphocytes infiltrating melanoma metastases after administration of autologous dinitrophenyl-modified vaccine ...
*  Agricultural biotechnology
... molecular markers, molecular diagnostics, vaccines, and tissue culture, to modify living organisms: plants, animals, and ...
*  Vaccine
The first DIVA vaccines (formerly termed marker vaccines and since 1999 coined as DIVA vaccines) and companion diagnostic tests ... Examples include the polio vaccine, hepatitis A vaccine, rabies vaccine and some influenza vaccines.[citation needed] Some ... the HPV vaccine, and the chicken pox vaccine. The World Health Organization (WHO) reports that licensed vaccines are currently ... the two vaccines can interfere. This most frequently occurs with live attenuated vaccines, where one of the vaccine components ...
*  David M. Knipe
"Next Generation Herpes Simplex Virus Vaccines"". Vaccine. 32 (14): 1561-1562. doi:10.1016/j.vaccine.2014.01.052. ISSN 0264-410X ... Knipe developed a cotransfection method for marker rescue mapping of mutations and introduction of new sequences into the HSV ... His work has shown that replication-defective viruses can serve as a genital herpes vaccine and as a vaccine vector-one of ... Da Costa, X. J.; Jones, C. A.; Knipe, D. M. (1999). "Immunization against genital herpes with a vaccine virus that has defects ...
*  Vaccine-induced seropositivity
See the table "HBV serological markers in hepatitis patients" frequently asked questions about HIV vaccine VISP. ... HIV vaccines have been tested continually worldwide since then, but thus far, no one has developed any vaccine which reduces a ... Vaccine-induced seropositivity or VISP is the phenomenon wherein a person who has received a vaccine against a disease would ... HIV vaccine research happens worldwide to ensure that any vaccine which researchers develop could be used for people worldwide ...
*  Tumor antigen
Certain tumor antigens are thus used as tumor markers. More importantly, tumor antigens can be used in cancer therapy as tumor ... antigen vaccines. Cancer immunotherapy Restifo, NP; Dudley, ME; Rosenberg, SA (Mar 22, 2012). "Adoptive immunotherapy for ... Tumor antigens are useful tumor markers in identifying tumor cells with diagnostic tests and are potential candidates for use ...
*  LAG3
... as potential serological markers of T helper-type cytokine response induced by acellular pertussis vaccine". International ... Scientists at the University of Tokyo showed that LAG-3 was a marker of Tregs that secrete IL-10. In 2010 scientists at Swiss ... In 1999 Triebel showed that LAG-3 could be used as a cancer vaccine, through cancer cell lines transfected with LAG-3. In 2001 ... In 2013 scientists at the San Raffaele Scientific Institute in Milan showed that LAG3 was a marker of type 1 Tregs. In 2014 ...
*  Cholangiocarcinoma
Changes in CA19-9 tumor marker are being assessed in a clinical trial of oral vaccine Immunitor V3-X. Landis S, Murray T, ... Studies of the performance of serum markers for cholangiocarcinoma (such as carcinoembryonic antigen and CA19-9) in patients ... "Serum and bile markers for cholangiocarcinoma". Semin Liver Dis. 24 (2): 139-54. doi:10.1055/s-2004-828891. PMID 15192787. ...
*  Salk Hall
"Salk Polio Vaccine". Pennsylvania Historical & Museum Commission: Historical Markers. Retrieved 2010-10-20. "Internet Archive: ... The Art Deco building is named after Jonas Salk, who conducted his research on the first polio vaccine in a basement laboratory ...
*  Mesothelin
... the protein could be exploited as tumor marker or as the antigenic target of a therapeutic cancer vaccine. A 2016 review ... a tumor marker for patients with mesothelioma and ovarian cancer". Clin. Cancer Res. 12 (2): 447-53. doi:10.1158/1078-0432.CCR- ... and mesothelin proteins as markers in the serum of patients with malignant mesothelioma". J Thorac Oncol. 3 (8): 851-7. doi: ... "Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer". Mol. Cancer Ther. 7 (2): 286-96. doi: ...
*  Index of HIV/AIDS-related articles
... subunit HIV vaccine - sulfa drug - sulfonamides - superantigen - suppressor T cell - surrogate marker - surveillance - ... AIDS Vaccine 200 - AIDS Vaccine Advocacy Coalition - AIDS wasting syndrome - AIDS-related cancer - AIDS-related complex (ARC ... live vector vaccine - liver function test (LFT) - long terminal repeat sequence (LTR) - long-term nonprogressors - LTR - lumbar ... HIV vaccine trials network (HVTN) - HIV-1 - HIV-2 - HIV-associated dementia - HIV-related tuberculosis - HLA - Hodgkin's ...
*  Shahrokh Shariat
... markers, early detection, natural history, treatment, translational and outcomes research Gene, vaccine and immuno therapies ... Shariat's has been working on the discovery, testing, and validation of molecular markers associated with the biological and ... His research focuses on urologic oncology - molecular mechanisms, markers, early detection, natural history, treatment, ... markers, early detection, natural history, treatment, translational and outcomes research Translational research in bladder ...
*  List of MeSH codes (D20)
... poliovirus vaccine, inactivated MeSH D20.215.894.845 --- vaccines, marker MeSH D20.215.894.860 --- vaccines, subunit MeSH ... measles vaccine MeSH D20.215.894.899.404.500 --- measles-mumps-rubella vaccine MeSH D20.215.894.899.488 --- mumps vaccine MeSH ... hepatitis a vaccines MeSH D20.215.894.899.955.400 --- hepatitis b vaccines MeSH D20.215.894.899.970 --- yellow fever vaccine ... rubella vaccine MeSH D20.215.894.899.779.500 --- measles-mumps-rubella vaccine MeSH D20.215.894.899.790 --- saids vaccines MeSH ...
*  Index of oncology articles
... uvula vaccine adjuvant - vaccine therapy - vaccinia CEA vaccine - valacyclovir - valdecoxib - valerian - Valeriana officinalis ... tumor marker - tumor model - tumor necrosis factor - tumor suppressor gene - tumor-derived - tumor-specific antigen - TUR - ... whole cell vaccine - Wilms' tumor - Wobe-Mugos E x-ray - x-ray therapy - xenograft - xeroderma pigmentosum - xerogram - ... tumor antigen vaccine - tumor board review - tumor burden - tumor debulking - tumor infiltrating lymphocyte - tumor load - ...
*  Toxoid
... s are used as vaccines because they induce an immune response to the original toxin or increase the response to another ... antigen since the toxoid markers and toxin markers are preserved. For example, the tetanus toxoid is derived from the ... While patients may sometimes complain of side effects after a vaccine, these are associated with the process of mounting an ... The latter causes tetanus and is vaccinated against by the DTaP vaccine. Botulin is produced by Clostridium botulinum and ...
*  Ervin Yen
Hardzinski, Brian (October 17, 2016). "Oklahoma Lawmaker, Physician Ervin Yen Will Try Vaccine Mandate Again In 2017". KGOU. ... Greer, Kate (November 24, 2014). "First Asian American Legislator Elected in Oklahoma history: Historical Marker, But No ...
*  Gustav Gaudernack
Since ras peptide vaccines had to contain the mutations that was carried in each individual cancer patient, development of a ... He further generated monoclonal antibodies specific for the hematopoietic stem cell marker, CD34. A joint collaboration with ... Already during his period at the UiT, the idea of cancer vaccines came to Gaudernack's mind. The fact that cancer cell lines ... This was a first in man telomerase vaccine and these data formed the basis for an ongoing phase III trial (Telovax) sponsored ...
*  Synthetic immunology
Therapeutic vaccines treat and immunize patients already infected with a given disease. Provenge is an adoptive cell-transfer ... Another example is a T cell that targets only cells that display two separate markers. In 2016 John Lin, head of Pfizer's San ... Functions include using specific cell markers to target cells for destruction and or interfering with immune reactions. US Food ... vaccines, therapeutic antibodies and Toll-like receptor (TLR) agonists. The discipline emerged after 2010 following the ...
*  Correlates of immunity/correlates of protection
International AIDS Vaccine Initiative HIV Vaccine Trials Network. ... not just laboratory markers). Fowke KR, Nagelkerke NJ, Kimani J, et al. (November 1996). "Resistance to HIV-1 infection among ... The fact that the correlates of immunity/protection remain unclear is a significant barrier to HIV vaccine research. There is ... However, without knowing the correlates of immunity, scientists cannot know exactly what sort of immune response a vaccine ...
*  Neisseria gonorrhoeae
... vaccines are thought to be an important goal in the prevention of infection. Development of a vaccine has been complicated by ... gonorrhoeae to disguise itself with different surface markers to evade the immune system). Neisseria gonnorhoeae is named for ... Vaccine. 32 (14): 1579-1587. doi:10.1016/j.vaccine.2013.08.067. ISSN 0264-410X. PMC 4682887 . PMID 24016806. Edwards, Jennifer ... There is currently no vaccine available for N. gonorrhoeae although efforts are underway to develop one. Because it is possible ...
*  Cervical cancer
The vaccines are between 92% and 100% effective against HPV 16 and 18 up to at least 8 years. HPV vaccines are typically given ... Bosch, FX; de Sanjosé, S (2007). "The epidemiology of human papillomavirus infection and cervical cancer". Disease markers. 23 ... The vaccines have been shown to be effective for at least four to six years, and they are believed to be effective for longer; ... HPV vaccines protect against between two and seven high-risk strains of this family of viruses and may prevent up to 90% of ...